title: [High risk prostate cancer results of one year RT-HT].
authors.affiliation: Service d'Urologie, Hôpital Salvator, Marseille, France.
authors.forename: Véronique
authors.initials: V
authors.lastname: Delaporte
authors.forename: Xavier
authors.initials: X
authors.lastname: Muracciole
authors.forename: Eric
authors.initials: E
authors.lastname: Lechevalier
authors.forename: Cyrille
authors.initials: C
authors.lastname: Bastide
authors.forename: Didier
authors.initials: D
authors.lastname: Cowen
authors.forename: Dominique
authors.initials: D
authors.lastname: Rossi
authors.forename: Christian
authors.initials: C
authors.lastname: Coulange
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000532:radiotherapy*; D000726:Androgen Antagonists / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D018572:Disease-Free Survival; D005500:Follow-Up Studies; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists* / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011446:Prospective Studies; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D020266:Radiotherapy, Conformal; D012307:Risk Factors
chemical_list: D000726:Androgen Antagonists; D007987:Gonadotropin-Releasing Hormone